Y08060

CAS No. 2222565-19-5

Y08060 ( Y 08060 )

Catalog No. M13549 CAS No. 2222565-19-5

Y08060 is a potent and selective BET inhibitor with Kd of 306 nM for BRD4 BD1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Y08060
  • Note
    Research use only, not for human use.
  • Brief Description
    Y08060 is a potent and selective BET inhibitor with Kd of 306 nM for BRD4 BD1.
  • Description
    Y08060 is a potent and selective BET inhibitor with Kd of 306 nM for BRD4 BD1, displays excellent selectivity for BET subfamily over other non-BET family with the exception of moderate inhibition of CBP/EP300; esuppresses cell growth, colony formation, and expression of androgen receptor (AR), AR regulated genes, and MYC in prostate cancer cell lines. such as C4-2B, LNCaP, and 22Rv1; demonstrates good PK profile with high oral bioavailability (61.54%).
  • Synonyms
    Y 08060
  • Pathway
    Chromatin/Epigenetic
  • Target
    Bromodomain
  • Recptor
    Bromodomain
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2222565-19-5
  • Formula Weight
    471.32
  • Molecular Formula
    C18H19BrN2O6S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    5-bromo-2-methoxy-N-(6-methoxy-2,2-dimethyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-7-yl)benzenesulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Xiang Q, et al. ACS Med Chem Lett. 2018 Feb 13;9(3):262-267.
molnova catalog
related products
  • GS-626510

    GS-626510 (GS-6510, GS 6510, GS 626510) is anovel BET family bromodomains inhibitor with Kd of 0.5-2.8 nM for BRD2/3/4, and BRDT.

  • GW 841819X

    GW 841819X is an analogue of (+)-JQ1 and a novel inhibitor of BET bromodomain.

  • Mivebresib

    Mivebresib (ABBV-075) is a potent and orally available BET bromodomain inhibitor with Ki of 1.0, 12.2, 1.5, and 2.2 nM for BRD2, BRD3, BRD4 and BRDT, respectively.